MCL-1-independent mechanisms of synergy between dual PI3K/mTOR and BCL-2 inhibition in diffuse large B cell lymphoma

J. Scott Lee(University of California, Irvine)
Oncotarget
October 9, 2015
Cited by 26


Related Papers

Statins enhance efficacy of venetoclax in blood cancers
|Science Translational Medicine|2018|86